Current Affairs

FabiFlu : Corona Virus drug launched for moderate COVID19 Cases.


Daily Current Affairs

FabiFlu : Corona Virus drug launched for moderate COVID19 Cases.

Glenmark Pharmaceuticals has launched the antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate Covid-19 patients at a price of about Rs 103 per tablet. The Drug firm received the manufacturing and marketing approval from the drug controller general of India  (DCGI). 

Highlights:

·         It's an anti-drug oral medicine favipiravir called fabiflu got first approved medication for the treatment of COVID19,

·         As per the recommended prescription of the first-day dose are 18 tablets with 9 tablets in the morning and 9 tablets in the evening,

·         Each strip pad contains a total 34 tablets of each 200 mg at a maximum retail price of rupees 3500/-

·         From the second day onwards, patients are required to take 4 tablets each in the morning and day. This treatment can be last up to 14 days to the age groups between 18 and 75.

·         Glenmark pharmaceuticals drug firm has ramping its production to satisfy the growing demand of the drug as confirmed cases of 39,5048 in India.


Daily Current Affairs

Also Read Current Affairs in Tamil, Current Affairs in English, Download Current pdf in Tamil, Download Current Affairs in English, Upcoming Jobs            

FabiFlu : Corona Virus drug launched for moderate COVID19 Cases.